Facephi Biometria, S.A. (BME:FACE)
Spain · Delayed Price · Currency is EUR 2.220
-0.040 (-1.77%)
Jun 5, 2026, 5:26 PM CET
Facephi Biometria Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 40.6 | 33.46 | 29.32 | 26.1 | 15.34 | |
Revenue Growth (YoY) | 21.34% | 14.11% | 12.35% | 70.19% | 83.09% |
Cost of Revenue | 10.29 | 13.31 | 3.43 | 3.22 | 1.9 |
Gross Profit | 30.31 | 20.15 | 25.9 | 22.88 | 13.44 |
Selling, General & Admin | 23.32 | 23.54 | 15.66 | 12.05 | 7.96 |
Other Operating Expenses | -3.47 | -2.48 | 9.62 | 6.5 | 4.83 |
Operating Expenses | 28.69 | 27.07 | 31.33 | 21.25 | 14.14 |
Operating Income | 1.62 | -6.92 | -5.43 | 1.63 | -0.71 |
Interest Expense | -0.84 | -1.52 | -1.71 | -0.3 | -0.39 |
Interest & Investment Income | 0.71 | 0.6 | 0.31 | 0 | 0 |
Currency Exchange Gain (Loss) | -1.22 | 0.26 | - | 0.38 | 0.32 |
Other Non Operating Income (Expenses) | 0.33 | 0.25 | 0.01 | -0.68 | -0.08 |
EBT Excluding Unusual Items | 0.59 | -7.33 | -6.82 | 1.03 | -0.85 |
Gain (Loss) on Sale of Assets | 0.52 | 2.09 | - | - | - |
Asset Writedown | -0.52 | -2.09 | - | - | - |
Other Unusual Items | -0.32 | - | -0.24 | - | - |
Pretax Income | 0.28 | -7.33 | -7.06 | 1.03 | -0.85 |
Income Tax Expense | -0.04 | 1.55 | -2.75 | -0.08 | -0.3 |
Net Income | 0.32 | -8.88 | -4.31 | 1.11 | -0.55 |
Net Income to Common | 0.32 | -8.88 | -4.31 | 1.11 | -0.55 |
Shares Outstanding (Basic) | 26 | 25 | 21 | 17 | 15 |
Shares Outstanding (Diluted) | 26 | 25 | 21 | 17 | 15 |
Shares Change (YoY) | 4.89% | 19.32% | 22.30% | 15.13% | 4.45% |
EPS (Basic) | 0.01 | -0.35 | -0.20 | 0.06 | -0.04 |
EPS (Diluted) | 0.01 | -0.35 | -0.20 | 0.06 | -0.04 |
Free Cash Flow | - | 0.48 | -0.66 | -7.39 | -3.91 |
Free Cash Flow Per Share | - | 0.02 | -0.03 | -0.43 | -0.26 |
Gross Margin | 74.66% | 60.21% | 88.32% | 87.65% | 87.61% |
Operating Margin | 3.99% | -20.70% | -18.51% | 6.24% | -4.60% |
Profit Margin | 0.78% | -26.55% | -14.70% | 4.24% | -3.61% |
Free Cash Flow Margin | - | 1.43% | -2.27% | -28.31% | -25.48% |
EBITDA | 2.16 | -6.38 | -4.77 | 1.79 | -0.62 |
EBITDA Margin | 5.33% | -19.07% | -16.28% | 6.85% | -4.06% |
D&A For EBITDA | 0.55 | 0.55 | 0.65 | 0.16 | 0.08 |
EBIT | 1.62 | -6.92 | -5.43 | 1.63 | -0.71 |
EBIT Margin | 3.99% | -20.70% | -18.51% | 6.24% | -4.60% |
Advertising Expenses | 0.05 | 0.05 | 1.22 | 1.02 | 0.69 |